Lee Kramm Email
Regulatory Affairs/Consultant . Eyenovia
How to contact Lee Kramm
Join and see Lee's contact info for free!
Current Roles
Employees:
83Revenue:
$12.9MAbout
Eyenovia, Inc. (NASDAQ: EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenoviaￃﾢ￢ﾂﾬ￢ﾄﾢs pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, glaucoma, mydriasis and other eye diseases.Eyenovia Address
New York, NY
United States